Skip to main navigation. Neuropace · Overview; Stock Information. Back; Stock Quote & Chart. News & Events. Back; News Releases · Events · Presentations. Stock analysis for NeuroPace Inc (NPCE:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Looking to buy NeuroPace Stock? View today's NPCE stock price, trade commission-free, and discuss NPCE stock updates with the investor community. Get the latest Neuropace Inc (NPCE) real-time quote, historical performance, charts, and other financial information to help you make more informed trading. Stock Information. Back; Stock Quote & Chart. News & Events. Back; News Releases · Events · Presentations. Financial Information. Back; SEC Filings. Governance.
NeuroPace, Inc. (zheniya.ru): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock NeuroPace, Inc. | Nasdaq: NPCE | Nasdaq. View the latest NeuroPace Inc. (NPCE) stock price, news, historical charts, analyst ratings and financial information from WSJ. Today's High; $ Today's Low; $ 52 Week High; $ 52 Week Low; $ Stock Chart. Data Provided by Refinitiv. Minimum 15 minutes delayed. Historical daily share price chart and data for NeuroPace since adjusted for splits and dividends. The latest closing stock price for NeuroPace as of. A high-level overview of NeuroPace, Inc. (NPCE) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and. Track NeuroPace Inc (NPCE) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable. Neuropace Inc NPCE:NASDAQ · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date02/20/24 · 52 Week Low · 52 Week. Stock price history for NeuroPace (NPCE). Highest end of day price: $ CAD on Lowest end of day price: $ CAD on As of Sep the stock price of NeuroPace is $ What is the current market cap of NeuroPace? The current market capitalization of NeuroPace is $M. View NeuroPace, Inc. NPCE stock quote prices, financial information, real-time forecasts, and company news from CNN. stock-based compensation, a noncash expense. NeuroPace continues to expect (in thousands, except share and per share amounts), , Revenue.
The latest NeuroPace stock prices, stock quotes, news, and NPCE history to help you invest and trade smarter. NeuroPace, Inc. develops, manufactures, and markets implantable devices for treating epilepsy and neurological disorders. It offers implantable components. NeuroPace (NASDAQ:NPCE) Full Year Results Key Financial Results Revenue: US$m (up 44% from FY ). Net. NeuroPace (NPCE) has a Smart Score of 8 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund Activity. The average price target is $ with a high forecast of $ and a low forecast of $ The average price target represents a % change from the. The stock is at the lower part of a very wide and horizontal trend in the short term, and normally this may pose a good buying opportunity, though a breakdown. Discover real-time Neuropace, Inc. Common Stock (NPCE) stock prices, quotes, historical data, news, and Insights for informed trading and investment. The Investor Relations website contains information about Neuropace's business for stockholders, potential investors, and financial analysts. Find the latest historical data for Neuropace, Inc. Common Stock (NPCE) at zheniya.ru View historical data in a monthly, bi-annual, or yearly format.
Get Neuropace Inc (zheniya.ru) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments. 29 minutes ago. Neuropace stock quote and NPCE charts. Latest stock price today and the US' most active stock market forums. NeuroPace Stock (NASDAQ: NPCE) stock price, news, charts, stock research, profile. On average, Wall Street analysts predict that Neuropace's share price could reach $ by Aug 14, The average Neuropace stock price prediction forecasts.
READY TO MOVE HIGHER : NPCE STOCK ANALYSIS - NEUROPACE STOCK
Market Cap Chart Since the IPO on April 22, , NeuroPace's market cap has decreased from $M to $M, a decrease of %. That is a compound. Get stock insights, analysis and discussion about Neuropace Inc (NDAQ:NPCE). Join the NPCE discussion on Canada's largest online investor community. See the latest NeuroPace Inc stock price (NPCE:XNAS), related news, valuation, dividends and more to help you make your investing decisions.
Warren Buffett Just SOLD! Is The Market Crashing?
Best Syrup Dispenser | 10 Percent Off Priceline